Skyscape Web Viewer : Davis's Drug Guide for Nurses : Pharmacologic Index

View All
macrolides clarithromycin fidaxomicin azithromycin erythromycin
Mechanistic target of rapamycin kinase inhibitors
meglitinides repaglinide nateglinide
melanocortin receptor agonists bremelanotide afamelanotide setmelanotide
melatonin receptor agonists ramelteon tasimelteon
metabolic inhibitors
mineralocorticoid receptor antagonists non steroidal
minerals electrolytes magnesium sulfate (parenteral) fluoride supplements
monamine oxidase inhibitors phenelzine isocarboxazid tranylcypromine
monoamine oxidase type b inhibitors rasagiline selegiline safinamide
monobactams aztreonam/avibactam aztreonam
mast cell stabilizers
microsomal transfer protein inhibitors
monoclonal antibodies adalimumab alirocumab anifrolumab avelumab basiliximab benralizumab bimekizumab burosumab cemiplimab cetuximab crizanlizumab daratumumab datopotamab deruxtecan dinutuximab dostarlimab elotuzumab emapalumab eptinezumab alemtuzumab amivantamab atezolizumab axatilimab belimumab bevacizumab blinatumomab caplacizumab certolizumab concizumab crovalimab daratumumab/hyaluronidase denosumab donanemab durvalumab elranatamab emicizumab erenumab evolocumab faricimab galcanezumab golimumab ibritumomab inebilizumab ipilimumab lanadelumab lecanemab margetuximab mogamulizumab naxitamab nirsevimab obinutuzumab ocrelizumab/hyaluronidase evinacumab fam-trastuzumab deruxtecan fremanezumab gemtuzumab ozogamicin guselkumab idarucizumab infliximab isatuximab lebrikizumab loncastuximab tesirine mepolizumab natalizumab necitumumab nivolumab ocrelizumab ofatumumab omalizumab pertuzumab polatuzumab vedotin ravulizumab risankizumab rituximab/hyaluronidase satralizumab tafasitamab teplizumab tezepelumab trastuzumab tremelimumab ustekinumab vilobelimab pembrolizumab pertuzumab/trastuzumab/hyaluronidase ranibizumab reslizumab rituximab rozanolixizumab secukinumab talquetamab teprotumumab tildrakizumab trastuzumab/hyaluronidase ublituximab vedolizumab
monoclonal anti-toxins raxibacumab obiltoxaximab
muscarinic agonists